Drug prices and value for money - The Australian Pharmaceutical Benefits Scheme

被引：78

作者：

Henry, DA

Hill, SR

Harris, A

机构：

[1] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia

[2] Monash Univ, Ctr Hlth Econ, Clayton, Vic 3168, Australia

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 294卷 / 20期

关键词：

D O I：

10.1001/jama.294.20.2630

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2630 / 2632

页数：3

共 18 条

[1]

[Anonymous], PHARM PRIC CONTR OEC

[2] The 'NICE' approach to technology assessment: An economics perspective [J].

Birch S. ;

Gafni A. .

Health Care Management Science, 2004, 7 (1) :35-41

[3] A cost-effectiveness approach to drug subsidy and pricing in Australia [J].

Birkett, DJ ;

Mitchell, AS ;

McManus, P .

HEALTH AFFAIRS, 2001, 20 (03) :104-114

[4] Wrong SIGN, NICE mess: is national guidance distorting allocation of resources? [J].

Cookson, R ;

McDaid, D ;

Maynard, A .

BRITISH MEDICAL JOURNAL, 2001, 323 (7315) :743-745

[5]

HARRIS AH, 2005, INT HLTH EC ASS 5 WO

[6] Will the Australia-United States free trade agreement undermine the pharmaceutical benefits scheme? [J].

Harvey, KJ ;

Faunce, TA ;

Lokuge, B ;

Drahos, P .

MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (05) :256-259

[7] Changes to the Pharmaceutical Benefits Advisory Committee [J].

Henry, DA ;

Birkett, DJ .

MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (05) :209-210

[8]

HILL S, 2001, INFORMING JUDGEMENT

[9] Problems with the interpretation of pharmacoeconomic analyses - A review of submissions to the Australian pharmaceutical benefits scheme [J].

Hill, SR ;

Mitchell, AS ;

Henry, DA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (16) :2116-2121

[10]

Laupacis A, 2005, MED CARE, V43, P15

← 1 2 →